ALDX
#3987
Aldeyra Therapeutics, Inc. - Common Stock
1.4 9 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.25%
Monthly Change
-8.59%
6 month change
-72.41%
Year Change
-74.40%
Previous Close
1.5 4
Open
1.4 9
Low
1.4 9
High
1.4 9
Volume
12
Financials
- Market Capitalization 89.89 M
- Employee 6
- Founded 2004
- CEO Todd C. Brady M.D., Ph.D.
- Website www.aldeyra.com
- Headquarter Delaware, United States
- FIGI BBG0029H8ZF6
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-9.25
Price to sales ratio
-1 164
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3973 |  PYPD PolyPid Ltd. - Ordinary Shares | 5.07 USD | -0.98% | -0.98% | +22.76% | +49.56% | 92.29 M USD | ||
| 3978 |  ICCC ImmuCell Corporation - Common Stock | 9.94 USD | -0.80% | -1.19% | -9.72% | +58.03% | 90.28 M USD | ||
| 3994 |  RLYB Rallybio Corporation - Common Stock | 16.81 USD | +0.30% | +1.63% | +5.66% | +3132.69% | 89.27 M USD | ||
| 3997 |  ACRV Acrivon Therapeutics, Inc. - Common Stock | 2.06 USD | -4.19% | -5.94% | +44.06% | +57.25% | 88.28 M USD |
Frequently asked questions about Aldeyra Therapeutics, Inc.
What is the Aldeyra Therapeutics, Inc. stock price today?
The current price of Aldeyra Therapeutics, Inc. (ALDX) is 1.49. Over the past 24 hours, the stock has changed by -3.25%. Follow the ALDX chart for real-time price dynamics.
What is the stock ticker of Aldeyra Therapeutics, Inc.?
Aldeyra Therapeutics, Inc. trades under the ticker ALDX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Aldeyra Therapeutics, Inc. stock going up?
ALDX has changed by -2.61% over the last week, -8.59% over the last month, and -74.40% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Aldeyra Therapeutics, Inc.?
Aldeyra Therapeutics, Inc. currently has a market capitalization of 89.89 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Aldeyra Therapeutics, Inc. earnings last quarter?
Last quarter, Aldeyra Therapeutics, Inc. reported earnings of -0.09 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Aldeyra Therapeutics, Inc. revenue for the last quarter?
Aldeyra Therapeutics, Inc. reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Aldeyra Therapeutics, Inc. net income for the last quarter?
Aldeyra Therapeutics, Inc. reported net income of -5.45 M for the last quarter. The previous quarter showed -3.45 M, which means net income changed by -57.86%.
How many employees does Aldeyra Therapeutics, Inc. have?
As of the latest available data, Aldeyra Therapeutics, Inc. has 6 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Aldeyra Therapeutics, Inc. stock?
You can buy Aldeyra Therapeutics, Inc. (ALDX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Aldeyra Therapeutics, Inc. stock?
Investing in Aldeyra Therapeutics, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ALDX chart and related analysis on metatrader.com as part of your research.